Leerink Upgrades Eli Lilly, Sees Obesity Market Dominance

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded10 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2198644

Show notes

Leerink Partners upgrades Eli Lillys stock, predicting a dominant position in the obesity treatment market. Key factors driving this optimism include expected Medicare and Medicaid coverage, new drug launches, and Eli Lillys ability to balance pricing and sales volume. Analysts anticipate strong revenue and profit growth, with revenue projected to reach $78.1 billion in 2026 and $125 billion by 2030.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.